Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Special Features of Adaptive Immunity

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Immunological Memory

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

Microbial Interactions: Parasitism

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Top Five Advances in Solid Organ Transplantation in the Past Fifty Years.

World journal of surgery·2026

Same author

Decoding the Mechanism of Action of a Parasite TGFβ Antagonist Inspires the Creation of Cell-Type-Specific TGFβ Modulators.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

CD160-competent ILC2 are crucial for the ejection of intestinal helminths by the innate immune system.

Mucosal immunology·2026

Same author

Molecular Engineering of the Helminth TGF-β Mimetics, TGM1 and TGM4, Reveals a Novel Antagonist of TGF-β Signaling in Fibroblasts.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Same author

Transcriptomic and Proteomic Analyses Show Minimal Role for ST2 on MCPT5-Expressing Mast Cells in Primary Heligmosomoides polygyrus bakeri Infection.

Parasite immunology·2026

Same author

Dynamics of Interleukin-9 Producing Lymphocytes in <i>Strongyloides ratti</i>-Infected Mice.

Pathogens (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: May 8, 2026

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

Helminths and immunological tolerance.

Chris J C Johnston¹, Henry J McSorley, Stephen M Anderton

¹1 Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK. 2 MRC Centre for Inflammation Research, University of Edinburgh, Queens Medical Research Institute, Edinburgh, UK. 3 Address correspondence to: Rick M. Maizels, Institute of Immunology and Infection Research, University of Edinburgh, West Mains Road, Edinburgh, EH9 3JT, UK.

Transplantation

|September 13, 2013

Summary

This summary is machine-generated.

Helminth parasites may offer a novel approach to achieving immunological tolerance in organ transplantation, potentially freeing recipients from lifelong immunosuppression. Research suggests helminths modulate immune responses beneficially, reducing rejection and improving transplant outcomes.

More Related Videos

Isolation of Murine Lymph Node Stromal Cells

Isolation of Murine Lymph Node Stromal Cells

Published on: August 19, 2014

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Related Experiment Videos

Last Updated: May 8, 2026

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

Isolation of Murine Lymph Node Stromal Cells

Isolation of Murine Lymph Node Stromal Cells

Published on: August 19, 2014

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Area of Science:

Immunology
Transplantation Science
Parasitology

Background:

Current immunosuppression for solid-organ transplantation has limited efficacy against chronic rejection and carries significant risks.
Achieving immunological tolerance, or long-term antigen unresponsiveness, offers the potential for freedom from immunosuppression.
Translating immunological tolerance from animal models to clinical practice remains a significant challenge.

Purpose of the Study:

To review existing studies on helminth infection and transplantation.
To explore the immunomodulatory mechanisms by which helminths influence transplant outcomes.
To discuss the potential for translating helminth-derived strategies into clinical practice for achieving transplant tolerance.

Main Methods:

Systematic review of literature on helminth infection and transplantation.
Analysis of studies investigating helminth-induced immunomodulation.
Exploration of mechanisms underlying helminth-host immune interactions relevant to transplantation.

Main Results:

Helminth infections are widespread and characterized by active host immune modulation.
Helminth-induced immunomodulation can reduce allergic and autoimmune conditions.
Evidence suggests helminths may abrogate harmful immune responses to alloantigens, relevant to transplantation.

Conclusions:

Helminth parasites represent a promising avenue for developing novel strategies to induce immunological tolerance in organ transplantation.
Understanding helminth-induced immunomodulation may lead to therapies that reduce allograft rejection and the need for conventional immunosuppression.
Further research is warranted to translate these findings into safe and effective clinical applications for transplant recipients.